Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE

Approved

STANDARD

HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE

Laboratorios Basi Industria Farmaceutica S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 23, 2023
Approval ID: 0a16debff9e117b3
Company: Laboratorios Basi Industria Farmaceutica S.A.
Type: Standard

Approval Details

Approval Id: 0a16debff9e117b3
Drug Cima Aemps Name: HIDROXOCOBALAMINA BASI 1 MG/ML SOLUCION INYECTABLE
Register Number: 88743
Holder Company Name: Laboratorios Basi Industria Farmaceutica S.A.
Marketing Company Name: Laphysan S.A.U.
Authorization Date: 2023-03-23
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 1 mg/ml
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratorios Basi Industria Farmaceutica S.A.

Active Ingredients

HIDROXOCOBALAMINA HIDROCLORURO

1,027 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 23, 2023

Approval ID

0a16debff9e117b3

Type

Standard

Back to CIMA-AEMPS Approvals